MedTrace Logo

Green Coffee Effect on Metabolic Syndrome

NCT05688917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2023-05-26

No results posted yet for this study

Summary

The present study aimed to investigate the effect of green coffee bean extract (GCBE) on the inflammatory biomarkers in obese patients with a metabolic syndrome via analyzing some inflammatory biomarkers as resistin, TNF-α, total sialic acid, homocysteine, high sensitivity C-reactive protein (hs-CRP) and anti-inflammatory cytokine, adiponectin

Conditions

Interventions

DIETARY_SUPPLEMENT

Green coffee been extract

supportive treatment

OTHER

Placebo

Placebo capsule

Sponsors & Collaborators

  • Damanhour University

    collaborator OTHER

  • Tanta University

    lead OTHER

Principal Investigators

  • Rehab H Werida, Ass. Prof. · Damanhour University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-03
Primary Completion
2022-09-01
Completion
2022-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05688917 on ClinicalTrials.gov